Home > Financial Ratios > GLAND PHARMA

GLAND PHARMA
Net Sales Growth

    Back to All Ratios
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Net Sales Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Net Sales Growth(%) 14.50-0.8556.29-17.6427.08

What is the latest Net Sales Growth ratio of GLAND PHARMA ?

The latest Net Sales Growth ratio of GLAND PHARMA is 14.50 based on Mar2026 Consolidated results.
Year Net Sales Growth
Mar202614.50
Mar2025-0.85
Mar202456.29
Mar2023-17.64
Mar202227.08

How is Net Sales Growth of GLAND PHARMA Trending?

Years Net Sales Growth % Change
Mar2026 14.5
Positive
Mar2025 -0.85
Negative
Mar2024 56.29
Positive
Mar2023 -17.64
Negative
Mar2022 27.08 -

Other Financial Ratios of GLAND PHARMA


Compare Net Sales Growth ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹46,548.2 Cr -0.8% 16.2% 44% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹459,952.0 Cr 1% -2.9% 17.4% Stock Analytics
DIVIS LABORATORIES ₹230,427.0 Cr 1.8% 17% 39.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹187,141.0 Cr -1.9% -1.9% 33.2% Stock Analytics
CIPLA ₹114,715.0 Cr 0.3% 0.7% -7.4% Stock Analytics
DR REDDYS LABORATORIES ₹99,409.9 Cr 1.7% 3.5% -4.1% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-0.8%

16.2%

44%

SENSEX

0.5%

2.1%

-4.5%


You may also like the below Video Courses